Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BJSE:920729'
s FCF Margin % Range Over the Past 10 Years
Min: -5.92 Med: 17.53 Max: 39.07
Current: 25.72
During the past 12 years, the highest FCF Margin % of Guangdong Winsun Bio Pharmaceutical Co was 39.07%. The lowest was -5.92%. And the median was 17.53%.
BJSE:920729's FCF Margin % is ranked better than 92.28% of 958
companies
in the Biotechnology industry
Industry Median: -74.685
vs BJSE:920729: 25.72
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangdong Winsun Bio Pharmaceutical Co FCF Margin % Chart
Guangdong Winsun Bio Pharmaceutical Co Annual Data
BJSE:920729 vs VRTX, REGN, RVMD: FCF Margin % Comparison
For the Biotechnology subindustry, Guangdong Winsun Bio Pharmaceutical Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangdong Winsun Bio Pharmaceutical Co FCF Margin % vs Biotechnology Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangdong Winsun Bio Pharmaceutical Co (BJSE:920729) has a FCF Margin % of 3.19% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Guangdong Winsun Bio Pharmaceutical Co and its competitors. This is 82% below median its historical median of 17.53. According to the industry distribution chart, Guangdong Winsun Bio Pharmaceutical Co ranks #74 out of 958 companies in the Biotechnology industry, placing it in the top 7.7%.
Is Guangdong Winsun Bio Pharmaceutical Co's FCF Margin % too high?
Guangdong Winsun Bio Pharmaceutical Co's current FCF Margin % of 3.19% is 82% below median its 10-year median of 17.53. Based on the distribution chart, Guangdong Winsun Bio Pharmaceutical Co ranks #74 out of 958 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Guangdong Winsun Bio Pharmaceutical Co has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Guangdong Winsun Bio Pharmaceutical Co's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Guangdong Winsun Bio Pharmaceutical Co ranks #74 out of 958 companies for FCF Margin %. This places Guangdong Winsun Bio Pharmaceutical Co in the top 8% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Guangdong Winsun Bio Pharmaceutical Co and its competitors. Guangdong Winsun Bio Pharmaceutical Co's current FCF Margin % is 3.19%, which is 82% below median its own 10-year median of 17.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangdong Winsun Bio Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Guangdong Winsun Bio Pharmaceutical Co (BJSE:920729) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥5.67, compared to a current price of ¥7.00 — trading 23.5% above its estimated fair value. The current FCF Margin % is 3.19%, which is 82% below median its 10-year median of 17.53. Guangdong Winsun Bio Pharmaceutical Co's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Guangdong Winsun Bio Pharmaceutical Co (BJSE:920729), the current FCF Margin % is 3.19% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guangdong Winsun Bio Pharmaceutical Co (BJSE:920729) Overvalued in 2026?
Based on GuruFocus' analysis, Guangdong Winsun Bio Pharmaceutical Co stock appears to be overvalued.
The current stock price of ¥7.00 is trading 23.5% above its estimated GF Value™ of ¥5.67.
GuruFocus considers Guangdong Winsun Bio Pharmaceutical Co to be Modestly Overvalued.
Key valuation signals for BJSE:920729:
FCF Margin %: 3.19% (82% below median its 10-year median of 17.53)
GF Value™: ¥5.67 vs. price of ¥7.00 (23.5% above fair value)
No single metric tells the full story. See the BJSE:920729 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guangdong Winsun Bio Pharmaceutical Co Ltd is involved in the field of veterinary biological products. It is an enterprise integrating research and development, production, sales, and service of veterinary biological products. It engages in the production of embryotoxin live vaccines, cytotoxic live vaccines, bacterial live vaccines, avian influenza inactivated vaccines, cytotoxic inactivated vaccines, embryotoxin inactivated vaccines, bacterial inactivated vaccines, swine fever live vaccines (rabbit source); veterinary use of Biological products.
74GF Score
Get the complete analysis for BJSE:920729
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920729 has been successfully added to your 
